Health status versus utilities of patients with end-stage liver disease

By Bryce Cindy L.   Angus Derek C.   Switala JoAnn   Roberts Mark S.   Tsevat Joel  

Quality of Life Research, Vol. 13, Iss. 4, 2004-05 ,pp. : 773-782

Springer Publishing Company

Access to resources Recommend Favorite

Randomized, Double-blind, Placebo-controlled Trial of Coenzyme Q10 in Patients with End-stage Renal Failure

By Singh Ram B.   Kumar Adarsh   Niaz Mohammad A.   Singh Rana G.   Gujrati Saurabh   Singh Vijaya P.   Singh Mandavi   Singh Udaj P.   Taneja Charu   Rastogi Shanti S.  

Journal of Nutritional & Environmental Medicine, Vol. 13, Iss. 1, 2003-03 ,pp. : 13-22

Informa Healthcare

Access to resources Recommend Favorite

Differences in Health-Related Quality of Life and Treatment Preferences Among Black and White Patients with End-Stage Renal Disease

By Hicks LeRoi S.   Cleary Paul D.   Epstein Arnold M.   Ayanian John Z.  

Quality of Life Research, Vol. 13, Iss. 6, 2004-08 ,pp. : 1129-1138

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Depression on Physician–Patient Communication Among Hispanic End-Stage Renal Disease Patients

By Gonzalez Amelia Victoria   Siegel Jason T.   Alvaro Eusebio M.   O'Brien Erin Keely  

Journal of Health Communication, Vol. 18, Iss. 5, 2013-05 ,pp. : 485-497

Taylor & Francis Ltd

Access to resources Recommend Favorite

Outcomes Associated with a Disease Management Program for End-Stage Renal Disease

By Nissenson A.R.  

Disease Management & Health Outcomes, Vol. 10, Iss. 2, 2002-01 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite